Comments

HCA Healthcare Inc Analyst Ratings

HCANYSE
Trade with Public
Trade with Public
$535.22
3.750.71%
At close: Feb 11, 4:00 PM EST
$541.46
9.991.88%
Pre-Market: 4:04 AM EST
OverviewNewsEarningsOptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGovernment TradesStock Report
Consensus Rating1
Buy
Highest Price Target1
$598.00
Lowest Price Target1
$332.00
Consensus Price Target1
$490.96

HCA Healthcare Analyst Ratings and Price Targets | NYSE:HCA | Benzinga

HCA Healthcare Inc has a consensus price target of $490.96 based on the ratings of 27 analysts. The high is $598 issued by UBS on January 28, 2026. The low is $332 issued by JP Morgan on May 30, 2024. The 3 most-recent analyst ratings were released by Argus Research, Wells Fargo, and Jefferies on February 6, 2026, January 30, 2026, and January 28, 2026, respectively. With an average price target of $543.67 between Argus Research, Wells Fargo, and Jefferies, there's an implied 0.41% upside for HCA Healthcare Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

16
2
Oct 25
1
Nov 25
1
1
Dec 25
9
2
Jan
1
Feb
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Argus Research
Wells Fargo
Jefferies
Oppenheimer
RBC Capital

1calculated from analyst ratings

Analyst Ratings for HCA Healthcare

Buy NowGet Alert
02/06/2026Buy Now3.42%Argus Research$530 → $560MaintainsBuyGet Alert
01/30/2026Buy Now-11.17%Wells Fargo$452 → $481MaintainsEqual-WeightGet Alert
01/28/2026Buy Now8.96%Jefferies$535 → $590MaintainsBuyGet Alert
01/28/2026Buy Now-0.27%Oppenheimer$500 → $540MaintainsOutperformGet Alert
01/28/2026Buy Now2.5%RBC Capital$525 → $555MaintainsOutperformGet Alert
01/28/2026Buy Now10.44%UBS$525 → $598MaintainsBuyGet Alert
01/28/2026Buy Now8.6%Cantor Fitzgerald$525 → $588MaintainsOverweightGet Alert
01/28/2026Buy Now0.84%Truist Securities$520 → $546MaintainsBuyGet Alert
01/28/2026Buy Now1.58%Keybanc$500 → $550MaintainsOverweightGet Alert
01/28/2026Buy Now3.05%Deutsche Bank$500 → $558MaintainsBuyGet Alert
01/28/2026Buy Now1.76%Barclays$494 → $551MaintainsOverweightGet Alert
01/07/2026Buy Now-16.52%Wells Fargo$431 → $452MaintainsEqual-WeightGet Alert
12/18/2025Buy Now-3.96%Mizuho$505 → $520MaintainsOutperformGet Alert
12/15/2025Buy Now-21.51%Morgan Stanley$425 → $425DowngradeEqual-Weight → UnderweightGet Alert
11/13/2025Buy Now-20.4%Wells Fargo$412 → $431MaintainsEqual-WeightGet Alert
10/28/2025Buy Now-3.04%Jefferies$485 → $525MaintainsBuyGet Alert
10/27/2025Buy Now-3.04%UBS$495 → $525MaintainsBuyGet Alert
10/27/2025Buy Now-13.2%B of A Securities$430 → $470MaintainsNeutralGet Alert
10/27/2025Buy Now-3.96%Goldman Sachs$470 → $520MaintainsBuyGet Alert
10/27/2025Buy Now-9.5%TD Cowen$380 → $490MaintainsBuyGet Alert
10/27/2025Buy Now-10.98%RBC Capital$449 → $482MaintainsOutperformGet Alert
10/27/2025Buy Now-8.77%Barclays$445 → $494MaintainsOverweightGet Alert
10/27/2025Buy Now-7.66%Stephens & Co.$450 → $500MaintainsOverweightGet Alert
10/27/2025Buy Now-8.58%Truist Securities$460 → $495MaintainsBuyGet Alert
10/27/2025Buy Now-7.66%Oppenheimer$400 → $500MaintainsOutperformGet Alert
10/27/2025Buy Now-6.73%Mizuho$475 → $505MaintainsOutperformGet Alert
10/27/2025Buy Now-12.27%Keybanc$465 → $475MaintainsOverweightGet Alert
10/17/2025Buy Now-12.27%Mizuho$425 → $475MaintainsOutperformGet Alert
10/14/2025Buy Now-8.58%UBS$438 → $495MaintainsBuyGet Alert
10/14/2025Buy Now-13.2%Goldman Sachs → $470Assumes → BuyGet Alert
10/08/2025Buy Now-14.12%Keybanc$370 → $465MaintainsOverweightGet Alert
10/07/2025Buy Now-23.91%Wells Fargo$375 → $412MaintainsEqual-WeightGet Alert
10/07/2025Buy Now-18%Cantor Fitzgerald$444 → $444ReiteratesOverweight → OverweightGet Alert
09/18/2025Buy Now-17.81%Barclays$390 → $445MaintainsOverweightGet Alert
09/10/2025Buy Now-24.28%B of A Securities$375 → $410MaintainsNeutralGet Alert
08/26/2025Buy Now-18%Cantor Fitzgerald$444 → $444ReiteratesOverweight → OverweightGet Alert
08/14/2025Buy Now-21.88%Baird$380 → $423MaintainsNeutralGet Alert
08/14/2025Buy Now-30.74%Wells Fargo$385 → $375MaintainsEqual-WeightGet Alert
08/04/2025Buy Now-31.67%JP Morgan$360 → $370MaintainsNeutralGet Alert
07/28/2025Buy Now-27.97%Barclays$416 → $390MaintainsOverweightGet Alert
07/28/2025Buy Now-25.94%RBC Capital$404 → $401MaintainsOutperformGet Alert
07/28/2025Buy Now-26.13%Morgan Stanley$410 → $400MaintainsEqual-WeightGet Alert
07/28/2025Buy Now—Wolfe Research—DowngradeOutperform → Peer PerformGet Alert
07/16/2025Buy Now-23.36%Truist Securities$390 → $415MaintainsBuyGet Alert
07/16/2025Buy Now-24.28%B of A Securities$394 → $410DowngradeBuy → NeutralGet Alert
06/23/2025Buy Now-25.39%RBC Capital$376 → $404MaintainsOutperformGet Alert
06/09/2025Buy Now-24.28%Morgan Stanley$355 → $410MaintainsEqual-WeightGet Alert
06/02/2025Buy Now-23.17%Barclays$366 → $416MaintainsOverweightGet Alert
05/29/2025Buy Now-28.9%Wells Fargo$320 → $385UpgradeUnderweight → Equal-WeightGet Alert
05/13/2025Buy Now-24.28%B of A Securities$370 → $410MaintainsBuyGet Alert
04/28/2025Buy Now-30.56%RBC Capital$384 → $376MaintainsOutperformGet Alert
04/15/2025Buy Now-37.95%Baird$396 → $336DowngradeOutperform → NeutralGet Alert
04/09/2025Buy Now—Guggenheim—Initiates → NeutralGet Alert
01/27/2025Buy Now-29.08%RBC Capital$405 → $384MaintainsOutperformGet Alert
01/27/2025Buy Now-31.67%B of A Securities$380 → $370MaintainsBuyGet Alert
01/27/2025Buy Now-25.2%Cantor Fitzgerald$405 → $405ReiteratesOverweight → OverweightGet Alert
01/27/2025Buy Now-32.4%Barclays$392 → $366MaintainsOverweightGet Alert
01/07/2025Buy Now-31.67%Keybanc$420 → $370MaintainsOverweightGet Alert
01/06/2025Buy Now-27.97%Truist Securities$430 → $390MaintainsBuyGet Alert
12/17/2024Buy Now-34.44%Morgan Stanley$406 → $355MaintainsEqual-WeightGet Alert
12/17/2024Buy Now-29.82%JP Morgan → $380Assumes → NeutralGet Alert
11/25/2024Buy Now-40.9%Wells Fargo$400 → $320DowngradeEqual-Weight → UnderweightGet Alert
11/22/2024Buy Now—Raymond James—DowngradeOutperform → Market PerformGet Alert
11/08/2024Buy Now-27.6%Barclays$396 → $392MaintainsOverweightGet Alert
11/06/2024Buy Now-26.13%Wells Fargo$395 → $400MaintainsEqual-WeightGet Alert
10/28/2024Buy Now-18.74%TD Cowen$450 → $440MaintainsBuyGet Alert
10/28/2024Buy Now-22.43%Keybanc$475 → $420MaintainsOverweightGet Alert
10/28/2024Buy Now-26.13%Oppenheimer$390 → $400MaintainsOutperformGet Alert
10/22/2024Buy Now-27.05%Wells Fargo$365 → $395MaintainsEqual-WeightGet Alert
10/11/2024Buy Now-12.27%Keybanc → $475Initiates → OverweightGet Alert
10/04/2024Buy Now-27.6%Cantor Fitzgerald$392 → $392ReiteratesOverweight → OverweightGet Alert
10/01/2024Buy Now-27.6%Cantor Fitzgerald$392 → $392ReiteratesOverweight → OverweightGet Alert
09/03/2024Buy Now-21.14%Morgan Stanley → $427Initiates → Equal-WeightGet Alert
08/23/2024Buy Now-25.2%RBC Capital$378 → $405MaintainsOutperformGet Alert
08/20/2024Buy Now-27.6%Cantor Fitzgerald$392 → $392ReiteratesOverweight → OverweightGet Alert
08/19/2024Buy Now-27.6%Cantor Fitzgerald$392 → $392ReiteratesOverweight → OverweightGet Alert
08/19/2024Buy Now-20.58%Truist Securities$390 → $430MaintainsBuyGet Alert
08/14/2024Buy Now-19.11%UBS$405 → $438MaintainsBuyGet Alert
07/30/2024Buy Now-32.59%Wells Fargo$315 → $365MaintainsEqual-WeightGet Alert
07/25/2024Buy Now-27.6%Cantor Fitzgerald$335 → $392MaintainsOverweightGet Alert
07/24/2024Buy Now-38.13%Cantor Fitzgerald$335 → $335ReiteratesOverweight → OverweightGet Alert
07/24/2024Buy Now-30.19%RBC Capital$329 → $378MaintainsOutperformGet Alert
07/24/2024Buy Now-26.86%Barclays$376 → $396MaintainsOverweightGet Alert
07/24/2024Buy Now-26.86%Leerink Partners$367 → $396MaintainsOutperformGet Alert
07/24/2024Buy Now-27.97%Oppenheimer$345 → $390MaintainsOutperformGet Alert
07/24/2024Buy Now-27.97%Truist Securities$375 → $390MaintainsBuyGet Alert
07/10/2024Buy Now-30.56%Barclays$367 → $376MaintainsOverweightGet Alert
07/10/2024Buy Now-38.13%Cantor Fitzgerald$335 → $335ReiteratesOverweight → OverweightGet Alert
07/09/2024Buy Now-38.13%Cantor Fitzgerald$335 → $335ReiteratesOverweight → OverweightGet Alert
07/02/2024Buy Now-38.13%Cantor Fitzgerald$335 → $335ReiteratesOverweight → OverweightGet Alert
06/28/2024Buy Now-30.74%Deutsche Bank$359 → $375MaintainsBuyGet Alert
05/30/2024Buy Now-38.68%JP Morgan$327 → $332MaintainsNeutralGet Alert
05/30/2024Buy Now-26.86%Baird → $396Initiates → OutperformGet Alert
04/30/2024Buy Now-33.51%TD Cowen$371 → $360MaintainsBuyGet Alert
04/29/2024Buy Now-32.22%Barclays$356 → $367MaintainsOverweightGet Alert
04/29/2024Buy Now-39.24%RBC Capital$322 → $329MaintainsOutperformGet Alert
04/29/2024Buy Now-36.28%Oppenheimer$330 → $345MaintainsOutperformGet Alert
04/12/2024Buy Now-33.7%Deutsche Bank$330 → $359MaintainsBuyGet Alert
04/10/2024Buy Now-38.13%Cantor Fitzgerald$335 → $335ReiteratesOverweight → OverweightGet Alert
03/28/2024Buy Now-41.82%Wells Fargo$303 → $315MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for HCA Healthcare (HCA) stock?

A

The latest price target for HCA Healthcare (NYSE:HCA) was reported by Argus Research on February 6, 2026. The analyst firm set a price target for $560.00 expecting HCA to rise to within 12 months (a possible 3.42% upside). 53 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for HCA Healthcare (HCA)?

A

The latest analyst rating for HCA Healthcare (NYSE:HCA) was provided by Argus Research, and HCA Healthcare maintained their buy rating.

Q

When was the last upgrade for HCA Healthcare (HCA)?

A

The last upgrade for HCA Healthcare Inc happened on May 29, 2025 when Wells Fargo raised their price target to $385. Wells Fargo previously had an underweight for HCA Healthcare Inc.

Q

When was the last downgrade for HCA Healthcare (HCA)?

A

The last downgrade for HCA Healthcare Inc happened on December 15, 2025 when Morgan Stanley changed their price target from $425 to $425 for HCA Healthcare Inc.

Q

When is the next analyst rating going to be posted or updated for HCA Healthcare (HCA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HCA Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HCA Healthcare was filed on February 6, 2026 so you should expect the next rating to be made available sometime around February 6, 2027.

Q

Is the Analyst Rating HCA Healthcare (HCA) correct?

A

While ratings are subjective and will change, the latest HCA Healthcare (HCA) rating was a maintained with a price target of $530.00 to $560.00. The current price HCA Healthcare (HCA) is trading at is $541.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved